PhosPrint is a laser bioprinter developer focusing on the highly precise and rapid delivery of cells and other bio-inks on the substrates of interest for tissue regeneration, printed diagnostics and biosensor applications.
events | press releases | media coverage
PhosPrint is proud to announce its participation in the EU funded project “UroPrint” under the H2020-FETOPEN-2018-2020 call
PhosPrint is proud to announce its participation in the EU funded project “Tumor-LN-oC” under the H2020 NMBP-23-2020 call
Our co-founder and CTO Ioanna Zergioti was awarded with the 3D printing award at SPIE Photonics West 2020, 3 February in San Francisco as a recognition for the fundamental work in the development of a single step laser bioprinting and immobilization process that offers a significant step towards research of cell properties confined in scaffold environments.
PhosPrint qualifies for the semi-finals of the SPIE Startup Challenge 2020 at the SPIE Photonics West Conference!
PhosPrint receives the Seal of Excellence from the European Commission, for its high-quality project proposal, in a highly competitive evaluation process, submitted under the Horizon 2020 SME Instrument Phase 1 call H2020-EIC-SMEInst-2018-2020 (H2020-SMEInst-2018-2020-1)